SEC Form 4/A · accession 0001209191-16-141805
LEMAITRE VASCULAR INC · LMAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
David B Roberts
Officer — President and Director · Director
Period of report
Sep 14, 2016
Accepted (ET)
Sep 16, 2016 · 4:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001158895
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 14, 2016 | S | 30,000 | $20.3333 | D | 79,793 | D | |
| Common StockF1,F3 | Sep 15, 2016 | S | 3,548 | $21.0235 | D | 76,245 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- F2The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $20.18 to $20.55. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
- F3The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $21.00 to $21.14. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
Remarks
This Form 4/A is filed solely to specify that the Reporting Person's sales were effected pursuant to a Rule 10b5-1 trading plan.